fbpx
< All Topics
Print

Identification of Natural SARS-CoV-2 Infection in Seroprevalence Studies Among Vaccinated Populations

Publication:

National Library of Medicine | February 14th, 2022

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841164/

Author(s):

Ryan T. Demmer, Brett Baumgartner, Talia D. Wiggen, Angela K. Ulrich, Ali J. Strickland, Brianna M. Naumchik, Bruno Bohn, Sara Walsh, Stephen Smith, Susan Kline, Steve D. Stovitz, Stephanie Yendell, Timothy J. Beebe, and Craig Hedberg

Quansys Products Used:

Q-Plex™ SARS- CoV-2 Human IgG (4-Plex)

Q-Plex™ SARS-CoV-2 Human IgG (5-Plex)

Abstract:

Most SARS-CoV-2 antibody assays cannot distinguish between antibodies that developed after natural infection and those that developed after vaccination. We assessed the accuracy of a nucleocapsid-containing assay in identifying natural infection among vaccinated individuals. A longitudinal cohort composed of health care workers in the Minneapolis/St. Paul area was enrolled. Two rounds of seroprevalence studies separated by 1 month were conducted from November 2020 to January 2021 among 81 participants. Capillary blood from rounds 1 and 2 was tested for IgG antibodies against spike proteins by enzyme-linked immunosorbent assay (spike-only assay). During round 2, IgGs reactive to SARS-CoV-2 nucleocapsid protein (nucleocapsid-containing assay) were assessed. Vaccination status at round 2 was determined by self-report. Area under the curve was computed to determine the discriminatory ability of the nucleocapsid-containing assay for identification of recent infection. Participants had a mean age of 40 years (range, 23 to 66 years); 83% were female. Round 1 seroprevalence was 9.5%. Before round 2 testing, 46% reported vaccination. Among those not recently infected, in comparing vaccinated vs unvaccinated individuals, elevated levels of spike 1 (P<.001) and spike 2 (P=.01) were observed, whereas nucleocapsid levels were not statistically significantly different (P=.90). Among all participants, nucleocapsid response predicted recent infection with an area under the curve of 0.93 (95% CI, 0.88 to 0.99). Among individuals vaccinated more than 10 days before antibody testing, the specificity of the nucleocapsid-containing assay was 92%, whereas the specificity of the spike-only assay was 0%. An IgG assay identifying reactivity to nucleocapsid protein is an accurate predictor of natural infection among a partially vaccinated population, whereas a spike-only assay performed poorly.

Previous Diagnostic performance of a 5-plex malaria immunoassay